Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China

Published:2022-07-26 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Tung Tao-Hsin¹^ORCID,Lin Xiao-Qing²^ORCID,Chen Yan²^ORCID,Zhang Mei-Xian¹^ORCID,Zhu Jian-Sheng²^ORCID

Affiliation:

1. Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China

2. Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2099210

Reference26 articles.

1. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China

2. Resolution of coronavirus disease 2019 (COVID-19)

3. Willingness to get the COVID-19 vaccine with and without emergency use authorization

4. Development of an inactivated vaccine candidate for SARS-CoV-2

5. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study;Human Vaccines & Immunotherapeutics;2023-11-20

2. Relationship between COVID-19 vaccine hesitancy and willingness to pay for the booster dose of COVID-19 vaccine of oncology patients in Taizhou, China;Annals of Medicine;2023-02-25

3. Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia;Infectious Disease Reports;2022-12-11

4. Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis;Human Vaccines & Immunotherapeutics;2022-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3